Key result
Chymotrypsin-like protease (CLP) from human leukocytes aggregates platelets and stimulates serotonin secretion, whereas elastase-like protease (ELP) does not induce serotonin release or aggregation.
Why the study?
Do neutral proteases from blood leukocytes alter human platelet function in vitro?
Do neutral proteases from blood leukocytes alter human platelet function in vitro?
Neutral proteases from leukocytes, specifically CLP, can aggregate platelets and stimulate serotonin secretion, potentially contributing to platelet dysfunction in inflammatory states.
No takes yet. Share an insight, caveat, or question.
CLP may promote platelet activation in inflammation; hypothesis-generating for leukocyte protease roles in human thrombosis.
Bykowska et al. (1983) studied Healthy human platelets (in vitro). Neutral proteases from human leukocytes (ELP and CLP) vs. Control, pancreatic chymotrypsin, or thrombin was evaluated on Platelet destruction, serotonin release, and aggregation. Chymotrypsin-like protease (CLP) from human leukocytes aggregates platelets and stimulates serotonin secretion, whereas elastase-like protease (ELP) does not induce serotonin release or aggregation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: